Aaron Strobel, MD
Internal Medicine · Little Rock, ARNPI 1689917163
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (46.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.8% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2020 at $16,498 and has fallen 77.5% since, to $3,718 in 2025. Among internal medicine clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $139.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$20K
- Edwards Lifesciences$4K
- Abbott$4K
- Boston Scientific$2K
- Shockwave Medical, Inc$859
- Astellas Pharma US Inc$188
- plus $1K from 20 others
What the payments were for
- Grants$15,00047%
- Travel & lodging$6,81921%
- Food & beverage$9,44629%
- Education$9293%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 56 | $19,579 |
| Edwards Lifesciences | 43 | $4,152 |
| Abbott | 35 | $4,108 |
| Boston Scientific | 32 | $2,143 |
| Shockwave Medical, Inc | 17 | $859 |
| Astellas Pharma US Inc | 2 | $188 |
| Abiomed | 3 | $161 |
| E.r. Squibb & Sons, L.L.C. | 9 | $158 |
| Cardiovascular Systems Inc. | 3 | $131 |
| Novartis | 8 | $122 |
| Penumbra, Inc. | 1 | $109 |
| Asahi Intecc USA, Inc. | 1 | $76 |
| W. L. Gore & Associates, Inc. | 1 | $72 |
| Pfizer | 4 | $58 |
| Philips North America LLC | 3 | $49 |
| Heartflow, Inc. | 2 | $40 |
| Irhythm Technologies, Inc. | 2 | $36 |
| Baxter Healthcare | 1 | $28 |
| Angiodynamics, Inc. | 1 | $27 |
| Cvrx, Inc. | 1 | $21 |
| Atricure, Inc. | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Merck | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$2,766
- MitraClip$1,238
- TRICLIP$1,135
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,070
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$537
- SAPIEN 3 Ultra RESILIA$406
- Resolute$280
- Supera peripheral stent system$182
- HeartMate 3 Left Ventricular Assist Device$166
- Ensite Cardiac Mapping System$154
- NAVITOR$143
- WATCHMAN Access System$141
- Integrity$140
- Assurity Pacemaker$136
- PASCAL$129
- GENERAL - THERAPIES$117
- Indigo System$109
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$103
How this compares
$32,194 in reported general payments places this provider in the 95th percentile of 614 internal medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 410 | $351,749 |
| EntrestoSacubitril/Valsartan | 212 | $190,187 |
| JardianceEmpagliflozin | 50 | $44,512 |
| Repatha SureclickEvolocumab | 72 | $43,963 |
| XareltoRivaroxaban | 36 | $30,697 |
| BrilintaTicagrelor | 44 | $30,401 |
| Ezetimibe | 413 | $8,675 |
| VascepaIcosapent Ethyl | 21 | $7,075 |
| Repatha SyringeEvolocumab | 12 | $6,416 |
| Metoprolol Succinate | 440 | $6,340 |
| Ranolazine ErRanolazine | 60 | $5,937 |
| Atorvastatin Calcium | 530 | $5,109 |
| Rosuvastatin Calcium | 344 | $4,342 |
| Prasugrel Hcl | 35 | $3,155 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 78 | $3,129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $58 | $351,749410 claims |
| NovartisEntresto | $122 | $190,187212 claims |
| Boehringer IngelheimJardiance | $13 | $44,51250 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 614 internal medicine providers in Arkansas.
Other internal medicine in Little Rock
- Jeremy DavisLittle Rock$17K
- Ritesh RampureLittle Rock$13K
- Milton RoachLittle Rock$12K
- Michael CloudLittle Rock$10K
- Saul Rios HerreraLittle Rock$8K
- Zhangning ChenLittle Rock$8K
- Russell RoarkLittle Rock$7K
- Arpana EdalaLittle Rock$6K
- Srikanth VallurupalliLittle Rock$5K
- Devendra PatelLittle Rock$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.